Speaker illustration

Doctor Tonje Thorvaldsen

Karolinska Institute, Stockholm (Sweden)

Eligibility for EMPEROR trials in a real-world heart failure population: data from the Swedish heart failure registry

Event: Heart Failure 2019

Topic: Epidemiology, Prognosis, Outcome

Session: Rapid Fire 4 - Chronic heart failure - Pharmacology

Thumbnail

Predicting risk in patients hospitalized for acute decompensated heart failure and preserved ejection fraction (from the ARIC study community surveillance)

Event: ESC Congress 2016

Topic: Prognosis

Session: Heart failure / LV dysfunction

Thumbnail